Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 311

1.

Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation.

Blin P, Fauchier L, Dureau-Pournin C, Sacher F, Dallongeville J, Bernard MA, Lassalle R, Droz-Perroteau C, Moore N.

Stroke. 2019 Aug 8:STROKEAHA119025824. doi: 10.1161/STROKEAHA.119.025824. [Epub ahead of print]

PMID:
31390972
2.

Dietary Patterns and Their Relationship With the Perceptions of Healthy Eating in European Adolescents: The HELENA Study.

Giménez-Legarre N, Santaliestra-Pasías AM, Beghin L, Dallongeville J, de la O A, Gilbert C, González-Gross M, De Henauw S, Kafatos A, Kersting M, Leclerq C, Manios Y, Molnar D, Sjöström M, Widhalm K, Huybrechts I, Moreno LA; HELENA Study Group.

J Am Coll Nutr. 2019 Jul 9:1-11. doi: 10.1080/07315724.2019.1598900. [Epub ahead of print]

PMID:
31287966
3.

Relative validation of the adapted Mediterranean Diet Score for Adolescents by comparison with nutritional biomarkers and nutrient and food intakes: the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) study.

Aparicio-Ugarriza R, Cuenca-García M, Gonzalez-Gross M, Julián C, Bel-Serrat S, Moreno LA, Breidenassel C, Kersting M, Arouca AB, Michels N, Mouratidou T, Manios Y, Dallongeville J, Gottrand F, Widhalm K, Kafatos A, Molnár D, De Henauw S, Gunter MJ, Huybrechts I.

Public Health Nutr. 2019 Sep;22(13):2381-2397. doi: 10.1017/S1368980019001022. Epub 2019 Jun 17.

PMID:
31204628
4.

Prevalence and Treatment of Familial Hypercholesterolemia in France.

Bérard E, Bongard V, Haas B, Dallongeville J, Moitry M, Cottel D, Ruidavets JB, Ferrières J.

Can J Cardiol. 2019 Jun;35(6):744-752. doi: 10.1016/j.cjca.2019.02.013. Epub 2019 Feb 27.

PMID:
31151710
5.

Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database.

Blin P, Dureau-Pournin C, Benichou J, Bonello L, Dallongeville J, Danchin N, Falissard B, Thomas-Delecourt F, Jové J, Lassalle R, Droz C, Moore N.

Atherosclerosis. 2019 Feb;281:98-106. doi: 10.1016/j.atherosclerosis.2018.11.037. Epub 2018 Dec 7.

PMID:
30658197
6.

Does the Mediterranean Diet Protect against Stress-Induced Inflammatory Activation in European Adolescents? The HELENA Study.

Carvalho KMB, Ronca DB, Michels N, Huybrechts I, Cuenca-Garcia M, Marcos A, Molnár D, Dallongeville J, Manios Y, Schaan BD, Moreno L, de Henauw S, Carvalho LA.

Nutrients. 2018 Nov 15;10(11). pii: E1770. doi: 10.3390/nu10111770.

7.

Identification of a functional FADS1 3'UTR variant associated with erythrocyte n-6 polyunsaturated fatty acids levels.

Hermant X, Delay C, Flaig A, Luque-Bedregal J, Briand G, Bout MA, Cottel D, Wagner A, Arveiler D, Simon C, Ferrières J, Ruidavets JB, Laillet B, Amouyel P, Dallongeville J, Meirhaeghe A, Dumont J.

J Clin Lipidol. 2018 Sep - Oct;12(5):1280-1289. doi: 10.1016/j.jacl.2018.07.012. Epub 2018 Jul 31.

PMID:
30170993
8.

Xafran, a drug utilization study of rivaroxaban in stroke prevention in atrial fibrillation in France using a claim database.

Dallongeville J, Sacher F, Bouée S, Emery C, Bureau I, Gourmelen J, Fauchier L.

Therapie. 2018 Dec;73(6):449-460. doi: 10.1016/j.therap.2018.06.003. Epub 2018 Jul 10.

PMID:
30075870
9.

Determinants and outcome of multiple and early recurrent cervical artery dissections.

Compter A, Schilling S, Vaineau CJ, Goeggel-Simonetti B, Metso TM, Southerland A, Pezzini A, Kloss M, Touzé E, Worrall BB, Thijs V, Bejot Y, Reiner P, Grond-Ginsbach C, Bersano A, Brandt T, Caso V, Lyrer PA, Traenka C, Lichy C, Martin JJ, Leys D, Sarikaya H, Baumgartner RW, Jung S, Fischer U, Engelter ST, Dallongeville J, Chabriat H, Tatlisumak T, Bousser MG, Arnold M, Debette S; CADISP-plus Consortium.

Neurology. 2018 Aug 21;91(8):e769-e780. doi: 10.1212/WNL.0000000000006037. Epub 2018 Aug 1.

PMID:
30068628
10.

Comparison of the rates of stroke and acute coronary events in northern France.

Cottel D, Montaye M, Marécaux N, Amouyel P, Dallongeville J, Meirhaeghe A.

Eur J Prev Cardiol. 2018 Sep;25(14):1534-1542. doi: 10.1177/2047487318788921. Epub 2018 Jul 18.

PMID:
30019921
11.

Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.

Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, Paige E, Paul DS, Sweeting M, Burgess S, Bell S, Astle W, Stevens D, Koulman A, Selmer RM, Verschuren WMM, Sato S, Njølstad I, Woodward M, Salomaa V, Nordestgaard BG, Yeap BB, Fletcher A, Melander O, Kuller LH, Balkau B, Marmot M, Koenig W, Casiglia E, Cooper C, Arndt V, Franco OH, Wennberg P, Gallacher J, de la Cámara AG, Völzke H, Dahm CC, Dale CE, Bergmann MM, Crespo CJ, van der Schouw YT, Kaaks R, Simons LA, Lagiou P, Schoufour JD, Boer JMA, Key TJ, Rodriguez B, Moreno-Iribas C, Davidson KW, Taylor JO, Sacerdote C, Wallace RB, Quiros JR, Tumino R, Blazer DG 2nd, Linneberg A, Daimon M, Panico S, Howard B, Skeie G, Strandberg T, Weiderpass E, Nietert PJ, Psaty BM, Kromhout D, Salamanca-Fernandez E, Kiechl S, Krumholz HM, Grioni S, Palli D, Huerta JM, Price J, Sundström J, Arriola L, Arima H, Travis RC, Panagiotakos DB, Karakatsani A, Trichopoulou A, Kühn T, Grobbee DE, Barrett-Connor E, van Schoor N, Boeing H, Overvad K, Kauhanen J, Wareham N, Langenberg C, Forouhi N, Wennberg M, Després JP, Cushman M, Cooper JA, Rodriguez CJ, Sakurai M, Shaw JE, Knuiman M, Voortman T, Meisinger C, Tjønneland A, Brenner H, Palmieri L, Dallongeville J, Brunner EJ, Assmann G, Trevisan M, Gillum RF, Ford I, Sattar N, Lazo M, Thompson SG, Ferrari P, Leon DA, Smith GD, Peto R, Jackson R, Banks E, Di Angelantonio E, Danesh J; Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group.

Lancet. 2018 Apr 14;391(10129):1513-1523. doi: 10.1016/S0140-6736(18)30134-X. Erratum in: Lancet. 2018 Jun 2;391(10136):2212.

12.

Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis.

Charbonnel B, Simon D, Dallongeville J, Bureau I, Dejager S, Levy-Bachelot L, Gourmelen J, Detournay B.

Pharmacoecon Open. 2018 Jun;2(2):209-219. doi: 10.1007/s41669-017-0050-3.

13.

Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.

Grimaldi-Bensouda L, Danchin N, Dallongeville J, Falissard B, Furber A, Cottin Y, Bonello L, Morel O, Leclercq F, Puymirat E, Ghanem F, Delarche N, Benichou J, Abenhaim L; PGRx-Acute Coronary Syndrome Study Group.

Heart. 2018 Oct;104(19):1583-1592. doi: 10.1136/heartjnl-2017-312534. Epub 2018 Mar 13.

PMID:
29535227
14.

Sex Differences in Stroke Attack, Incidence, and Mortality Rates in Northern France.

Meirhaeghe A, Cottel D, Cousin B, Dumont MP, Marécaux N, Amouyel P, Dallongeville J.

J Stroke Cerebrovasc Dis. 2018 May;27(5):1368-1374. doi: 10.1016/j.jstrokecerebrovasdis.2017.12.023. Epub 2018 Feb 21.

PMID:
29429886
15.

Serum uric acid levels are associated with cardiovascular risk score: A post hoc analysis of the EURIKA study.

Borghi C, Rodriguez-Artalejo F, De Backer G, Dallongeville J, Medina J, Nuevo J, Guallar E, Perk J, Banegas JR, Tubach F, Roy C, Halcox JP.

Int J Cardiol. 2018 Feb 15;253:167-173. doi: 10.1016/j.ijcard.2017.10.045.

PMID:
29306459
16.

Inflammation in metabolically healthy and metabolically abnormal adolescents: The HELENA study.

González-Gil EM, Cadenas-Sanchez C, Santabárbara J, Bueno-Lozano G, Iglesia I, González-Gross M, Molnar D, Gottrand F, De Henauw S, Kafatos A, Widhalm K, Manios Y, Siani A, Amaro-Gahete F, Rupérez AI, Cañada D, Censi L, Kersting M, Dallongeville J, Marcos A, Ortega FB, Moreno LA; HELENA study group.

Nutr Metab Cardiovasc Dis. 2018 Jan;28(1):77-83. doi: 10.1016/j.numecd.2017.10.004. Epub 2017 Oct 13.

PMID:
29174028
17.

Inflammation and insulin resistance according to body composition in European adolescents: the HELENA study.

González-Gil E, Gracia-Marco L, Santabárbara J, Molnar D, Amaro Gahete FJ, Gottrand F, Arouca A, Kafatos A, Widhalm K, Manios Y, Siani A, González-Gross M, Gómez-Martínez S, Díaz LE, Leclerq C, Dallongeville J, Marcos A, Moreno Aznar LA.

Nutr Hosp. 2017 Oct 24;34(5):1033-1043. doi: 10.20960/nh.747.

18.

Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's Disease.

Chen Y, Sillaire AR, Dallongeville J, Skrobala E, Wallon D, Dubois B, Hannequin D, Pasquier F; Lille YOD study group.

J Alzheimers Dis. 2017;60(3):1045-1054. doi: 10.3233/JAD-170367.

19.

Changes over time in the prevalence and treatment of cardiovascular risk factors, and contributions to time trends in coronary mortality over 25 years in the Lille urban area (northern France).

Clement G, Giovannelli J, Cottel D, Montaye M, Ciuchete A, Dallongeville J, Amouyel P, Dauchet L.

Arch Cardiovasc Dis. 2017 Dec;110(12):689-699. doi: 10.1016/j.acvd.2017.03.009. Epub 2017 Sep 22.

20.

Score of Adherence to 2016 European Cardiovascular Prevention Guidelines Predicts Cardiovascular and All-Cause Mortality in the General Population.

Bérard E, Bongard V, Haas B, Dallongeville J, Moitry M, Cottel D, Ruidavets JB, Ferrières J.

Can J Cardiol. 2017 Oct;33(10):1298-1304. doi: 10.1016/j.cjca.2017.06.008. Epub 2017 Jun 23.

PMID:
28866076
21.

Dietary linoleic acid interacts with FADS1 genetic variability to modulate HDL-cholesterol and obesity-related traits.

Dumont J, Goumidi L, Grenier-Boley B, Cottel D, Marécaux N, Montaye M, Wagner A, Arveiler D, Simon C, Ferrières J, Ruidavets JB, Amouyel P, Dallongeville J, Meirhaeghe A.

Clin Nutr. 2018 Oct;37(5):1683-1689. doi: 10.1016/j.clnu.2017.07.012. Epub 2017 Jul 20.

PMID:
28774683
22.

Real-life cost of vitamin K antagonist treatment in patients with non-valvular atrial fibrillation in France in 2013.

Dallongeville J, Ansolabehere X, Karusisi N, Maurel F, Van Ganse E, Le Heuzey JY.

J Med Econ. 2017 Sep;20(9):974-981. doi: 10.1080/13696998.2017.1352508. Epub 2017 Jul 18.

PMID:
28682153
23.

Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.

Halcox JP, Banegas JR, Roy C, Dallongeville J, De Backer G, Guallar E, Perk J, Hajage D, Henriksson KM, Borghi C.

BMC Cardiovasc Disord. 2017 Jun 17;17(1):160. doi: 10.1186/s12872-017-0591-5.

24.

Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes: PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice).

Van Belle E, Baptista SB, Raposo L, Henderson J, Rioufol G, Santos L, Pouillot C, Ramos R, Cuisset T, Calé R, Teiger E, Jorge E, Belle L, Machado C, Barreau D, Costa M, Hanssen M, Oliveira E, Besnard C, Costa J, Dallongeville J, Pipa J, Sideris G, Fonseca N, Bretelle C, Guardado J, Lhoest N, Silva B, Barnay P, Sousa MJ, Leborgne L, Silva JC, Vincent F, Rodrigues A, Seca L, Fernandes R, Dupouy P; PRIME-FFR Study Group.

Circ Cardiovasc Interv. 2017 Jun;10(6). pii: e004296. doi: 10.1161/CIRCINTERVENTIONS.116.004296.

PMID:
28615234
25.

Prevalence of ideal cardiovascular health in European adolescents: The HELENA study.

Henriksson P, Henriksson H, Gracia-Marco L, Labayen I, Ortega FB, Huybrechts I, España-Romero V, Manios Y, Widhalm K, Dallongeville J, González-Gross M, Marcos A, Moreno LA, Castillo MJ, Ruiz JR; HELENA study group.

Int J Cardiol. 2017 Aug 1;240:428-432. doi: 10.1016/j.ijcard.2017.03.022.

PMID:
28606683
26.

Ideal cardiovascular health and liver enzyme levels in European adolescents; the HELENA study.

Labayen I, Ruiz JR, Huybrechts I, Ortega FB, Castillo M, Sjöstrom M, González-Gross M, Manios Y, Widhalm K, Kafatos A, Breidenassel C, Rodríguez G, Dallongeville J, Gottrand F, Moreno LA.

J Physiol Biochem. 2017 May;73(2):225-234. doi: 10.1007/s13105-016-0546-9. Epub 2017 Jan 6.

PMID:
28063097
27.

Comparison of definitions for the metabolic syndrome in adolescents. The HELENA study.

Vanlancker T, Schaubroeck E, Vyncke K, Cadenas-Sanchez C, Breidenassel C, González-Gross M, Gottrand F, Moreno LA, Beghin L, Molnár D, Manios Y, Gunter MJ, Widhalm K, Leclercq C, Dallongeville J, Ascensión M, Kafatos A, Castillo MJ, De Henauw S, Ortega FB, Huybrechts I; HELENA project group*.

Eur J Pediatr. 2017 Feb;176(2):241-252. doi: 10.1007/s00431-016-2831-6. Epub 2017 Jan 5.

PMID:
28058532
28.

Model-observational bridging study on the effectiveness of ezetimibe on cardiovascular morbidity and mortality in France: A population-based study.

Ferrières J, Dallongeville J, Rossignol M, Bénichou J, Caro JJ, Getsios D, Hernandez L, Abenhaim L, Grimaldi-Bensouda L.

J Clin Lipidol. 2016 Nov - Dec;10(6):1379-1388. doi: 10.1016/j.jacl.2016.08.015. Epub 2016 Sep 7.

PMID:
27919355
29.

Dietary sources of sugars in adolescents' diet: the HELENA study.

Mesana MI, Hilbig A, Androutsos O, Cuenca-García M, Dallongeville J, Huybrechts I, De Henauw S, Widhalm K, Kafatos A, Nova E, Marcos A, González-Gross M, Molnar D, Gottrand F, Moreno LA.

Eur J Nutr. 2018 Mar;57(2):629-641. doi: 10.1007/s00394-016-1349-z. Epub 2016 Nov 29.

PMID:
27896443
30.

The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals.

Ehret GB, Ferreira T, Chasman DI, Jackson AU, Schmidt EM, Johnson T, Thorleifsson G, Luan J, Donnelly LA, Kanoni S, Petersen AK, Pihur V, Strawbridge RJ, Shungin D, Hughes MF, Meirelles O, Kaakinen M, Bouatia-Naji N, Kristiansson K, Shah S, Kleber ME, Guo X, Lyytikäinen LP, Fava C, Eriksson N, Nolte IM, Magnusson PK, Salfati EL, Rallidis LS, Theusch E, Smith AJP, Folkersen L, Witkowska K, Pers TH, Joehanes R, Kim SK, Lataniotis L, Jansen R, Johnson AD, Warren H, Kim YJ, Zhao W, Wu Y, Tayo BO, Bochud M; CHARGE-EchoGen consortium; CHARGE-HF consortium; Wellcome Trust Case Control Consortium, Absher D, Adair LS, Amin N, Arking DE, Axelsson T, Baldassarre D, Balkau B, Bandinelli S, Barnes MR, Barroso I, Bevan S, Bis JC, Bjornsdottir G, Boehnke M, Boerwinkle E, Bonnycastle LL, Boomsma DI, Bornstein SR, Brown MJ, Burnier M, Cabrera CP, Chambers JC, Chang IS, Cheng CY, Chines PS, Chung RH, Collins FS, Connell JM, Döring A, Dallongeville J, Danesh J, de Faire U, Delgado G, Dominiczak AF, Doney ASF, Drenos F, Edkins S, Eicher JD, Elosua R, Enroth S, Erdmann J, Eriksson P, Esko T, Evangelou E, Evans A, Fall T, Farrall M, Felix JF, Ferrières J, Ferrucci L, Fornage M, Forrester T, Franceschini N, Duran OHF, Franco-Cereceda A, Fraser RM, Ganesh SK, Gao H, Gertow K, Gianfagna F, Gigante B, Giulianini F, Goel A, Goodall AH, Goodarzi MO, Gorski M, Gräßler J, Groves C, Gudnason V, Gyllensten U, Hallmans G, Hartikainen AL, Hassinen M, Havulinna AS, Hayward C, Hercberg S, Herzig KH, Hicks AA, Hingorani AD, Hirschhorn JN, Hofman A, Holmen J, Holmen OL, Hottenga JJ, Howard P, Hsiung CA, Hunt SC, Ikram MA, Illig T, Iribarren C, Jensen RA, Kähönen M, Kang H, Kathiresan S, Keating BJ, Khaw KT, Kim YK, Kim E, Kivimaki M, Klopp N, Kolovou G, Komulainen P, Kooner JS, Kosova G, Krauss RM, Kuh D, Kutalik Z, Kuusisto J, Kvaløy K, Lakka TA, Lee NR, Lee IT, Lee WJ, Levy D, Li X, Liang KW, Lin H, Lin L, Lindström J, Lobbens S, Männistö S, Müller G, Müller-Nurasyid M, Mach F, Markus HS, Marouli E, McCarthy MI, McKenzie CA, Meneton P, Menni C, Metspalu A, Mijatovic V, Moilanen L, Montasser ME, Morris AD, Morrison AC, Mulas A, Nagaraja R, Narisu N, Nikus K, O'Donnell CJ, O'Reilly PF, Ong KK, Paccaud F, Palmer CD, Parsa A, Pedersen NL, Penninx BW, Perola M, Peters A, Poulter N, Pramstaller PP, Psaty BM, Quertermous T, Rao DC, Rasheed A, Rayner NWNWR, Renström F, Rettig R, Rice KM, Roberts R, Rose LM, Rossouw J, Samani NJ, Sanna S, Saramies J, Schunkert H, Sebert S, Sheu WH, Shin YA, Sim X, Smit JH, Smith AV, Sosa MX, Spector TD, Stančáková A, Stanton A, Stirrups KE, Stringham HM, Sundstrom J, Swift AJ, Syvänen AC, Tai ES, Tanaka T, Tarasov KV, Teumer A, Thorsteinsdottir U, Tobin MD, Tremoli E, Uitterlinden AG, Uusitupa M, Vaez A, Vaidya D, van Duijn CM, van Iperen EPA, Vasan RS, Verwoert GC, Virtamo J, Vitart V, Voight BF, Vollenweider P, Wagner A, Wain LV, Wareham NJ, Watkins H, Weder AB, Westra HJ, Wilks R, Wilsgaard T, Wilson JF, Wong TY, Yang TP, Yao J, Yengo L, Zhang W, Zhao JH, Zhu X, Bovet P, Cooper RS, Mohlke KL, Saleheen D, Lee JY, Elliott P, Gierman HJ, Willer CJ, Franke L, Hovingh GK, Taylor KD, Dedoussis G, Sever P, Wong A, Lind L, Assimes TL, Njølstad I, Schwarz PE, Langenberg C, Snieder H, Caulfield MJ, Melander O, Laakso M, Saltevo J, Rauramaa R, Tuomilehto J, Ingelsson E, Lehtimäki T, Hveem K, Palmas W, März W, Kumari M, Salomaa V, Chen YI, Rotter JI, Froguel P, Jarvelin MR, Lakatta EG, Kuulasmaa K, Franks PW, Hamsten A, Wichmann HE, Palmer CNA, Stefansson K, Ridker PM, Loos RJF, Chakravarti A, Deloukas P, Morris AP, Newton-Cheh C, Munroe PB.

Nat Genet. 2016 Oct;48(10):1171-1184. doi: 10.1038/ng.3667. Epub 2016 Sep 12.

31.

Impact of cardiovascular risk factor control on long-term cardiovascular and all-cause mortality in the general population.

Bérard E, Bongard V, Dallongeville J, Arveiler D, Amouyel P, Wagner A, Cottel D, Haas B, Ruidavets JB, Ferrières J.

Ann Med. 2016 Nov;48(7):559-567. Epub 2016 Aug 25.

PMID:
27558835
32.

Association of body composition indices with insulin resistance in European adolescents: the HELENA study.

Sese M, Moreno LA, Censi L, Bresidenassel C, González-Gross M, Sjöström M, Manios Y, Dénes M, Dallongeville J, Widhalm K, Gottrand F, De-Henauw S, Marcos A, CastilloGarzón M, Jiménez-Pavón D.

Nutr Hosp. 2016 Jun 30;33(3):257. doi: 10.20960/nh.257. Spanish.

33.

The association between blood pressure and lipid levels in Europe: European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice.

Borghi C, Rodriguez-Artalejo F, De Backer G, Dallongeville J, Medina J, Guallar E, Perk J, Banegas JR, Tubach F, Roy C, Halcox JP.

J Hypertens. 2016 Nov;34(11):2155-63. doi: 10.1097/HJH.0000000000001078.

PMID:
27512970
34.

Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.

Van Belle E, Rauch A, Vincent F, Robin E, Kibler M, Labreuche J, Jeanpierre E, Levade M, Hurt C, Rousse N, Dally JB, Debry N, Dallongeville J, Vincentelli A, Delhaye C, Auffray JL, Juthier F, Schurtz G, Lemesle G, Caspar T, Morel O, Dumonteil N, Duhamel A, Paris C, Dupont-Prado A, Legendre P, Mouquet F, Marchant B, Hermoire S, Corseaux D, Moussa K, Manchuelle A, Bauchart JJ, Loobuyck V, Caron C, Zawadzki C, Leroy F, Bodart JC, Staels B, Goudemand J, Lenting PJ, Susen S.

N Engl J Med. 2016 Jul 28;375(4):335-44. doi: 10.1056/NEJMoa1505643.

35.

How obesity relates to socio-economic status: identification of eating behavior mediators.

Pigeyre M, Rousseaux J, Trouiller P, Dumont J, Goumidi L, Bonte D, Dumont MP, Chmielewski A, Duhamel A, Amouyel P, Dallongeville J, Romon M, Meirhaeghe A.

Int J Obes (Lond). 2016 Nov;40(11):1794-1801. doi: 10.1038/ijo.2016.109. Epub 2016 Jul 5.

PMID:
27377952
36.

Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study.

Borghi C, Tubach F, De Backer G, Dallongeville J, Guallar E, Medina J, Perk J, Roy C, Banegas JR, Rodriguez-Artalejo F, Halcox JP.

Int J Cardiol. 2016 Sep 1;218:83-88. doi: 10.1016/j.ijcard.2016.05.044. Epub 2016 May 13.

PMID:
27232917
37.

Association of heart rate and blood pressure among European adolescents with usual food consumption: The HELENA study.

Julián-Almárcegui C, Vandevijvere S, Gottrand F, Beghin L, Dallongeville J, Sjöstrom M, Leclercq C, Manios Y, Widhalm K, Ferreira De Morares AC, Gónzalez-Gross M, Stehle P, Castillo MJ, Moreno LA, Kersting M, Vyncke K, De Henauw S, Huybrechts I.

Nutr Metab Cardiovasc Dis. 2016 Jun;26(6):541-8. doi: 10.1016/j.numecd.2016.01.014. Epub 2016 Mar 21.

PMID:
27174584
38.

Food groups associated with a reduced risk of 15-year all-cause death.

Bongard V, Arveiler D, Dallongeville J, Ruidavets JB, Wagner A, Simon C, Marécaux N, Ferrières J.

Eur J Clin Nutr. 2016 Jun;70(6):715-22. doi: 10.1038/ejcn.2016.19. Epub 2016 Mar 2.

PMID:
26931670
39.

The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology.

De Smedt D, De Bacquer D, De Sutter J, Dallongeville J, Gevaert S, De Backer G, Bruthans J, Kotseva K, Reiner Ž, Tokgözoğlu L, Clays E.

Int J Cardiol. 2016 Apr 15;209:284-90. doi: 10.1016/j.ijcard.2016.02.015. Epub 2016 Feb 3.

40.

Correlates of dietary energy misreporting among European adolescents: the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) study.

Bel-Serrat S, Julián-Almárcegui C, González-Gross M, Mouratidou T, Börnhorst C, Grammatikaki E, Kersting M, Cuenca-García M, Gottrand F, Molnár D, Hallström L, Dallongeville J, Plada M, Roccaldo R, Widhalm K, Moreno LA, Manios Y, De Henauw S, Leclercq C, Vandevijvere S, Lioret S, Gutin B, Huybrechts I.

Br J Nutr. 2016 Apr;115(8):1439-52. doi: 10.1017/S0007114516000283. Epub 2016 Feb 18.

PMID:
26888046
41.

Multiple microRNA regulation of lipoprotein lipase gene abolished by 3'UTR polymorphisms in a triglyceride-lowering haplotype harboring p.Ser474Ter.

Caussy C, Charrière S, Meirhaeghe A, Dallongeville J, Lefai E, Rome S, Cuerq C, Euthine V, Delay M, Marmontel O, Di Filippo M, Lagarde M, Moulin P, Marçais C.

Atherosclerosis. 2016 Mar;246:280-6. doi: 10.1016/j.atherosclerosis.2016.01.010. Epub 2016 Jan 11.

PMID:
26820803
42.

Body Composition Indices and Single and Clustered Cardiovascular Disease Risk Factors in Adolescents: Providing Clinical-Based Cut-Points.

Gracia-Marco L, Moreno LA, Ruiz JR, Ortega FB, de Moraes AC, Gottrand F, Roccaldo R, Marcos A, Gómez-Martínez S, Dallongeville J, Kafatos A, Molnar D, Bueno G, de Henauw S, Widhalm K, Wells JC.

Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):555-64. doi: 10.1016/j.pcad.2015.11.002. Epub 2015 Nov 4.

PMID:
26545445
43.

Predictive Accuracy of the European Society of Cardiology SCORE Among French People.

Bérard E, Séguro F, Bongard V, Dallongeville J, Arveiler D, Amouyel P, Wagner A, Ruidavets JB, Ferrières J.

J Cardiopulm Rehabil Prev. 2016 Jan-Feb;36(1):38-48. doi: 10.1097/HCR.0000000000000148.

PMID:
26468633
44.

Expired-air carbon monoxide as a predictor of 16-year risk of all-cause, cardiovascular and cancer mortality.

Bérard E, Bongard V, Dallongeville J, Arveiler D, Amouyel P, Wagner A, Cottel D, Haas B, Ferrières J, Ruidavets JB.

Prev Med. 2015 Dec;81:195-201. doi: 10.1016/j.ypmed.2015.09.001. Epub 2015 Sep 9.

PMID:
26361750
45.

The n-3 long-chain PUFAs modulate the impact of the GCKR Pro446Leu polymorphism on triglycerides in adolescents.

Rousseaux J, Duhamel A, Dumont J, Dallongeville J, Molnar D, Widhalm K, Manios Y, Sjöström M, Kafatos A, Breidenassel C, Gonzales-Gross M, Cuenca-Garcia M, Censi L, Ascensión M, De Henauw S, Moreno LA, Meirhaeghe A, Gottrand F.

J Lipid Res. 2015 Sep;56(9):1774-80. doi: 10.1194/jlr.M057570. Epub 2015 Jul 1.

46.

Resting Heart Rate Is Not a Good Predictor of a Clustered Cardiovascular Risk Score in Adolescents: The HELENA Study.

de Moraes AC, Cassenote AJ, Leclercq C, Dallongeville J, Androutsos O, Török K, González-Gross M, Widhalm K, Kafatos A, Carvalho HB, Moreno LA.

PLoS One. 2015 May 26;10(5):e0127530. doi: 10.1371/journal.pone.0127530. eCollection 2015.

47.

Correction: Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project.

Vishram JK, Borglykke A, Andreasen AH, Jeppesen J, Ibsen H, Jørgensen T, Palmieri L, Giampaoli S, Donfrancesco C, Kee F, Mancia G, Cesana G, Kuulasmaa K, Salomaa V, Sans S, Ferrieres J, Dallongeville J, Söderberg S, Arveiler D, Wagner A, Tunstall-Pedoe H, Drygas W, Olsen MH; MORGAM Project.

PLoS One. 2015 May 15;10(5):e0128848. doi: 10.1371/journal.pone.0128848. eCollection 2015. No abstract available.

48.

Treatment maintenance duration of dual therapy with metformin and sitagliptin in type 2 diabetes: The ODYSSEE observational study.

Valensi P, de Pouvourville G, Benard N, Chanut-Vogel C, Kempf C, Eymard E, Moisan C, Dallongeville J.

Diabetes Metab. 2015 Jun;41(3):231-8. doi: 10.1016/j.diabet.2015.03.007. Epub 2015 May 12.

PMID:
25976701
49.

Age- and sex-specific causal effects of adiposity on cardiovascular risk factors.

Fall T, Hägg S, Ploner A, Mägi R, Fischer K, Draisma HH, Sarin AP, Benyamin B, Ladenvall C, Åkerlund M, Kals M, Esko T, Nelson CP, Kaakinen M, Huikari V, Mangino M, Meirhaeghe A, Kristiansson K, Nuotio ML, Kobl M, Grallert H, Dehghan A, Kuningas M, de Vries PS, de Bruijn RF, Willems SM, Heikkilä K, Silventoinen K, Pietiläinen KH, Legry V, Giedraitis V, Goumidi L, Syvänen AC, Strauch K, Koenig W, Lichtner P, Herder C, Palotie A, Menni C, Uitterlinden AG, Kuulasmaa K, Havulinna AS, Moreno LA, Gonzalez-Gross M, Evans A, Tregouet DA, Yarnell JW, Virtamo J, Ferrières J, Veronesi G, Perola M, Arveiler D, Brambilla P, Lind L, Kaprio J, Hofman A, Stricker BH, van Duijn CM, Ikram MA, Franco OH, Cottel D, Dallongeville J, Hall AS, Jula A, Tobin MD, Penninx BW, Peters A, Gieger C, Samani NJ, Montgomery GW, Whitfield JB, Martin NG, Groop L, Spector TD, Magnusson PK, Amouyel P, Boomsma DI, Nilsson PM, Järvelin MR, Lyssenko V, Metspalu A, Strachan DP, Salomaa V, Ripatti S, Pedersen NL, Prokopenko I, McCarthy MI, Ingelsson E; ENGAGE Consortium.

Diabetes. 2015 May;64(5):1841-52. doi: 10.2337/db14-0988. Epub 2015 Feb 23.

50.

Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.

Halcox JP, Tubach F, Lopez-Garcia E, De Backer G, Borghi C, Dallongeville J, Guallar E, Medina J, Perk J, Sazova O, Sweet S, Roy C, Banegas JR, Rodriguez-Artalejo F.

PLoS One. 2015 Feb 18;10(2):e0115270. doi: 10.1371/journal.pone.0115270. eCollection 2015.

Supplemental Content

Loading ...
Support Center